DrugPatentWatch Database Updates: New Patent Delistings
✉ Email this page to a colleague
DrugPatentWatch Database Updates: New Patent Delistings
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Usecode | Patented / Exclusive Use |
---|---|---|---|---|---|---|---|---|---|---|---|
Horizon Therap Us | RAVICTI | glycerol phenylbutyrate | LIQUID | 203284 | Feb 1, 2013 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | U-1383 | DOSAGE ADJUSTMENT OF A NITROGEN SCAVENGING DRUG IN THE TREATMENT OF A UREA CYCLE DISORDER |
Eli Lilly And Co | MOUNJARO (AUTOINJECTOR) | tirzepatide | SOLUTION | 215866 | May 13, 2022 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Eli Lilly And Co | MOUNJARO (AUTOINJECTOR) | tirzepatide | SOLUTION | 215866 | May 13, 2022 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE | 210496 | Jun 27, 2018 | DISCN | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE | 210496 | Jun 27, 2018 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
Neurocrine | ONGENTYS | opicapone | CAPSULE | 212489 | Apr 24, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | U-2812 | ADJUNCTIVE TREATMENT TO LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE |
Gilead Sciences Inc | VEKLURY | remdesivir | SOLUTION | 214787 | Oct 22, 2020 | RX | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |